3 December 2025CompletedHealthcare
HSI to acquire Sonnet BioTherapeutics Holdings, Inc.
HSI has agreed to acquire Sonnet BioTherapeutics Holdings, Inc. in a going private transaction valued at an undisclosed amount. The deal consideration consists of shares…
- Buyer
- HSI
- Target
- Sonnet BioTherapeutics Holdings, Inc.
- Deal value
- Not disclosed
- Deal type
- going private